摘要:
The invention relates to a kit comprising a pharmaceutical composition that contains repinotan or a physiologically acceptable salt of repinotan, and to a means for determining the concentration of repinotan or its metabolites in body fluids. The invention further relates to novel pharmaceutical compositions that contain repinotan or a physiologically acceptable salt of repinotan, and to a method for producing the same.
摘要:
The present invention relates to monoclonal antibodies binding to the N-terminal procollagen (III) propeptide (PIIINP) molecule which is a proteolytic fragment emanating from the specific cleavage of procollagen (III) by N-proteinase after exocytosis and to an assay using these antibodies.